MDx Firm Akonni Biosystems Seeks to Raise $8M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Akonni Biosystems is seeking to raise $8 million, it disclosed in a document filed on Monday with the US Securities and Exchange Commission.

In its filing, the Frederick, Md.-based firm said it has raised $912,598 in the private round of financing so far. It did not say how the funds will be used but said the offering is not being made in connection with a merger, acquisition or exchange offer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.